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Larry H. Bernsteina, Asad Qamarb, Craig McPhersonb, and
Stuart Zarichb
Departments ofaPathology and Laboratory Medicine andbinternal Medicine, Yale
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Objective: We used a new graphical ordinal logit method (GOLDminer) to assess a single cardiac
troponin T (cTnT) analysis at the time of admission (first generation monoclonal; Roche BMC
Corp., Indianapolis, Indiana), the characterofchestpain, andelectrocardiographic (ECG)findings
in predicting the likelihood ofacute myocardial infarction (AMI) in patients presenting with sus-
pectedmyocardial ischemia. Thefinal diagnosis ofAMIwas based on serialECGfindings and evo-
lution ofCKMB isoenzyme levels in conjunction with clinicalfindings.
Subjects: The studypopulation consistedof293 consecutivepatients whopresented ata mean ofsix
hours after onsetofchestpain orassociatedsymptoms warranting a "rule-out"forAMIassessment
to a university-affiliated community hospital.
Results: The odds-ratiofor an elevated cTnT(> 0.1 ng/ml) in AMI was 22.2:1. There was an asso-
ciation between typical chest pain and cTnT(chi square = 78.23, p < .0001) and between abnor-
mal ECGfindings and cTnT(chi square = 108, p < .0001). The cTnTyielded diagnostic benefit in
addition to chestpain characteristics and ECGfindings in AMI. Wepresent the odds-ratiosfor the
combinedfeatures in GOLDminerplots.
Conclusion: We demonstrate how the odds-ratiosforAMI are obtained after scaling continuous to
ordinal the valuesfor a single cTnT determination alone and with otherfeatures in patients pre-
senting with chestpain.
INTRODUCTION
The diagnosis of acute myocardial
infarction (AMI)b is problematic for many
patients who present with equivocal symp-
toms or electrocardiographic (ECG) find-
ings. Chestpain is associated with an over-
triage ofpatients to the coronary care unit
since less than one-third of chest pain
patients demonstrate creatine kinase
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isoenzyme MB (CKMB) changes [1-4].
Additionally, in nearly 10 percent of
patients, the diagnosis of AMI cannot be
definitively confirmed or excluded [5].
Although serial measurement of
blood CKMB is a widely used biochemi-
cal marker in the diagnosis ofAMI [6, 7],
CKMB levels typically are not increased
until nine hours after the onset of chest
pain. Given the late rise of CKMB, the
CKMB mass assay has less than 70 per-
cent sensitivity in the diagnosis ofAMI at
the time ofpresentation to the emergency
department [8]. Newer biochemical mark-
ers have been utilized to aid in the diagno-
sis ofAMI, including cTnT, which rises to
abnormal levels in serum within four to
sixhours after the onset of myocardial
damage, remains elevated for a week or
longer, and is associated with a significant
likelihood of cardiac events [9-14].
Despite conflicting views about which tro-
ponin is best to use, there is now a recom-
mendation for incorporating them in the
WHO guidelines for AMI diagnosis, with
special interest in their value for risk strat-
ifying patients with unstable angina [15].
There has also been a recommendation to
integrate the troponins with the Goldman
algorithm [16, 17]. We specifically chose
troponin T to study because there was
already a substantial literature about the
sensitivity of the assay and its value in
identifying a subset of unstable angina
patients with the same risk as AMI. The
value of the cardiac marker was not
proved for emergency room decisions
based on an initial blood sample taken at
the time patients present with chest pain.
We carried out this study by blinding the
physicians to the troponin results and pro-
posed that the laboratory can incorporate
this method in a clinical pathway for deci-
sions about the disposition ofpatients pre-
senting with clinical features suggestive of
AMI [18].
We describe a novel method for inter-
preting the clinical, electrocardiographic,
and the laboratory features ofpatients pre-
senting with suggested myocardial infarc-
tion. The result is not a binary response,
but rather a graded relationship that is
most useful forfitting the data to observed
outcomes and for predicting expected
responses. The decision-making method
described can reduce medical treatment
failure rates, lower the cost of managing
chest pain patients, and improve the deliv-
ery ofhealth care.
We examine cTnT levels at the time
of first sample as compared with chest
pain characteristics, ECG findings, and
serial CKMB determinations in consecu-
tive patients presenting to the emergency
department with symptoms and/or signs
suggestive of myocardial injury. Clini-
cians blinded to the results ofcTnT values
evaluated patients for the diagnosis of
AMI on clinical grounds in conjunction
with serial ECG findings and CKMB
results according to World Health
Organization criteria. We applied a uni-
versal probability model under bivariate
normality to estimate the odds-ratios for
eitherdichotomous orforpolytomous out-
comes in this study.
METHODS
Study sample
cTnT was measured on the first spec-
imen submitted for CKMB isoenzyme
analysis from each of 293 patients pre-
senting to the Bridgeport Hospital emer-
gency department with chest pain or
symptoms suspicious forAMI. The results
of cTnT were not provided to the
Bridgeport Hospital emergency depart-
ment physicians and clinicians caring for
the patient during their hospitalization.
All patients' records, ECGs, and hos-
pital discharge diagnoses were reviewed
without knowledge of the serum cTnT
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lized to obtain historical data and classify
patients as having typical or atypical chest
pain or other findings at presentation.
World Health Organization criteria were
used as the criterion for the diagnosis of
AMI.
Cardiac markers
cTnT was measured using the first
generation assay (Roche/BMC, Indian-
apolis, IN). A cTnT level of 0.1 ng/ml or
above was considered abnormal.
Statistical methods
We converted continuous data by
scaling to ordinal and examined relation-
ships between interval data and outcomes
[19, 20]. The World Health Organization
criteria depend on more than one feature
fordiagnosis: clinical, ECG, andrelease of
enzymes or proteins from damaged
myocardium. The optimum medical deci-
sion cutoffs were assigned using Rudolph
et al.'s [21] method of group-based refer-
ence.
Scaling the data and partitioning the
population into pattern classes: The data
were used to classify the patients whose
diagnoses were known (AMI, unstable
angina, and nonischemic chestpain). These
data were used in a classifying matrix sep-
arating the population into two classes,
AMI or not, based on cTnT less than 0.1
ng/ml, or equal to or greater than 0.1
ng/ml. The other clinical and laboratory
features were scaled: initial CKMB was
scaled to 0ifless than 17 U/I, and 1 ifequal
to or above 17 U/I [21]; and the CKMB
evolution was 0 if negative, and 1 if there
was typical evolution of AMI. The ECG
data were scaled to: 3, ST segment eleva-
tion; 2, Q waves; 1, ST segment depres-
sion/T wave inversion; 0, normal; -1, other.
The characteristics of the chest pain were
scaled to: 2, typical; 1, atypical; 0, other
presenting feature. cTnT was scaled to: -1,
<0.05; 0,0.05 to 0.099; 1,0.1 to 0.2; 2,0.2
to 0.5; 3, 0.5 to 1; 4, > 1 ng/ml.
Statistical analyses: The relationship
of scaled tests to diagnoses and clinical
features were examined using a universal
regression model under bivariate normali-
ty with estimation of generalized odds-
ratios. The model was developed by Jay
Magidson (Statistical Innovations, Inc.,
Belmont, Massachusetts) [19, 20] and is
available from Statistical Package for
Social Science with a graphical ordinal
logit display (GOLDminerTm). The uni-
versal regression model is a unified maxi-
mum likelihood method for simultaneous-
ly assessing the statistical significance of
treatment effects and the model fit when
the response variable is ordered. It uses a
"parallel log-odds" model based on adja-
cent odds to describe the data.
Justification of the universal regres-
sion model: The "universal" probability
model overcomes errors that arise from
using linear regression for ordered vari-
ables. The scaled data form a cross-table
that is used in the universal regression
Table 1. Observed frequency of cardiac troponinT concentration in ECG categories.
TnT/ECG Normal Other Q-wave ST dep ST ele
<0.05 56 125 6 12 4
0.05-0.1 4 15 1 2 0
0.1-0.2 0 6 0 4 1
0.2 - 0.5 0 6 0 5 5
0.5-1 0 2 1 3 8
> 1 0 6 2 10 9262 Bernstein et al.: GOLDminer method for diagnosis ofmyocardial infarction
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Figure 1. GOLDminerTMY-view of cTnT (ng/ml) against ECG findings. TheY-view dis-
plays the cardiac troponin T (trop) in ng/ml at intervals of: < 0.05, 0.05 to 0.099, 0.1 to 0.2,
0.2 to 0.5, 0.5 to 1, and >1 on the Y-axis versus the ECG finding on the X-axis. The ECG
findings are normal, other finding, Q-wave, ST depression or T-wave inversion (dep/inv),
and ST elevation (ST elev). The result ofY variable are regressed against X. The fit is sig-
nificant at chi -square = 108 (p = 2.7 x 10-25).The odds-ratios are equally spaced opposite
the troponin T values on the Y-axis. The crossing lines show the relationship of the value
on the Y-axis to the odds-ratio. A troponin T > 1 has an odds-ratio of 0.165 versus 34.226
against a normal ECG with a likelihood of ST-elevation. The symbols on the Y-axis are
arranged in order by relative distance on the X-axis.
analysis. The method allows us to look at
more than two values of the dependent
variable when the variable values are
ordered. When there are only two values,
the result is a logistic regression. The
odds-ratio represents the increase in the
odds associated with a change in condition
from baseline with respect to AMI.
RESULTS
A total of 141 patients (48 percent)
presented with chest pain (typical for 70
[24 percent]), and 152 (52 percent) had
associated symptoms (dyspnea, abdominal
discomfort, congestive heart failure, etc.).
Among the 60 patients (21 percent) with a
final diagnosis ofAMI, there was an even
distribution between Q-wave (QMI) and
non Q-wave AMI (non QMI). ECG fea-
tures clinically diagnostic of myocardial
ischemia or infarction were present in 73
patients (24 percent), while 160 patients
(55 percent) had non-diagnostic ECGs.
Sixty patients (21 percent) had a normal
presenting ECG.
A GOLDminerTm plot can be con-
structed in many ways. Forexample, when
the dependent variable is the ECG, ECG
findings are predicted by the cTnT, and the
association between AMI is significant
(p = 2.7 x 10-25). The predictor is scaled to
the intervals described. Table 1 is the
observed frequencies that give rise to the
GOLDminerTm plot (Y-view) shown in
Figure 1.Bernstein et al.: GOLDminer method fordiagnosis ofmyocardial infarction 263
Table 2. Odds for cardiac troponin T concentration versus ECG findings.
TnTIECG Normal Other 0-wave ST dep ST ele
<.05 1.023 2.457 0.120 0.244 0.067
.05-.1 0.654 2.187 0.148 0.421 0.160
.1 -.2 0.418 1.947 0.184 0.726 0.384
.2-.5 0.268 1.733 0.228 1.252 0.921
.5 - 1 0.171 1.543 0.282 2.160 2.212
> 1 0.109 1.374 0.350 3.725 5.310
ref 0.664 2.196 0.147 0.413 0.155
We review the steps required to get to
Figure 1. Each cell has an observed and
expected frequency. The probabilities of
each cell are obtained by dividing the
expected (or observed) frequency by the
total frequency for the column. The proba-
bilities add to 1. The odds-ratio is calculat-
ed by comparing the ratio of the Y-refer-
ence odds to the baseline or X-reference
odds. The odds are obtained by taking the
ratio of the frequency count for an out-
come category to that of the outcome ref-
erence. In this case the outcome reference
is the column "normal ECG." Considerthe
example of "cTnT < 0.05," and "cTnT > 1
with ST elevation" as the outcome and
"normal ECG" as the reference. The
expected odds for "cTnT < 0.05" or for
"cTnT > 1 with ST elevation" are
3.46/3.47 (= 1) and 13.19/3.47 (= 3.80)
using the axis-reference of 3.47. The
expected odds for "normal ECG" versus
"ST elevation with cTnT < 0.05" are
53.09/51.92 (= 1.02) and 3.46/51.92 (=
0.07) using the axis-reference of 51.92.
The axis-reference frequencies are hidden
from view in this presentation. The
expected odds for the cells are calculated
before calculating the odds-ratios. The Y-
reference may be displayed on therightfor
each row, and the X-reference may be dis-
played at the bottom of each column, but
the variables may also be reversed, partic-
ularly in this example. The importantpoint
is that calculation of odds prior to calcu-
lating the odds-ratio requires that the
entire Y-reference be converted to a value
of 1 by dividing all the cell frequencies by
the reference frequency. The odds-ratio is
next calculated by converting the X-refer-
ence to a baseline of 1.
Table 2 is the calculated odds that are
used for the odds-ratios shown in Figure 1
using a cTnT reference of 0.1 ng/ml. The
reference odds listed in the last row of
each column coincides with the odds at
cTnT < 0.1 (0.05 to 0.1). There is a refer-
ence odds for each column, or ECG cate-
gory. The odds-ratio is calculated for any
cTnT value in an ECG category with the
odds-ratio for cTnT < 0.1 as 1 by dividing
the odds by the reference odds. For exam-
ple, the expected odds-ratio for the table
cell cTnT > 1 and ST elevation is calculat-
ed as 5.310/0.155 = .26. Likewise, the
odds-ratio for cTnT < 0.05 and normal
ECG is calculated as 1.023/0.654 = 1.54.
The odds-ratio for cTnT 0.2 to 0.5 and Q-
wave is calculated as 0.228/0.147 = 1.55.
Figure 1 is a GOLDminerTm Y-view
of the scaled cTnT versus ECG findings
[15, 16], a graphical representation of the
results ofthe universal regression with the
odds-ratios displayed on the left side and
the cTnT scaled values evenly spaced on
the right side. The chi-square (108), sig-
nificant at p = 2.7x10-25, shows that the
uniform spacing fits the table. The signifi-
cance chi-square is the difference between
the chi-square for independence and the264 Bernstein etal.: GOLDminer method for diagnosis ofmyocardial infarction
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Figure 2. GOLDminerTM Y-view of binary 2 variable pattern versus AMI or non-AMI.
The pattern classes, as in Table 1, are displayed on the Y-axis. The troponin T and ECG
have binary values. The equally spaced odds-ratios are opposite the pattern classes. The
only classes represented on the X-axis are non-AMI (NAMI) and AMI. The symbols are
arranged in order by relative distance on the X-axis.The crossed lines show the expected
odds-ratios of the classes for and against NAMI/AMI. The fit of the classification is signifi-
cant at chi-square = 182.3 (p = 1.6 x 10-41).
Table 3. Observed and expected frequencies for cTnT, ECG versus diagnoses.
TnT,ECGJDx 0 1 2 3
(obs/exp)
2,4 0/0.09 0/0.56 0/5.56 21/14.79
1,4 0/0.10 0/0.23 0/0.84 2/0.84
2,3 3/2.26 6/4.37 22/13.39 0/10.98
0,4 3/1.40 0/1.23 0/1.72 2/0.64
1,3 2/3.56 4/2.57 4/2.96 0/0.91
2,2 0/1.31 0/0.78 0/0.73 3/0.19
0,3 49/47.81 13/12.96 5/5.59 0/0.64
2,1 1/0.81 0/0.15 0/0.04 0/0
0,2 5/6.39 1/0.53 0/0.07 1/0
0,1 85/83.76 1/2.16 0/0.09 0/0
0,0 59/59.52 1/0.47 0/0.01 0/0
chi-square for fit. The values for the pair-
ings for cTnT and categorical ECG results
are calculated from the expected odds as
described above.
The GOLDminerm plot is construct-
ed by converting the cTnT results from
continuous to ordinal data by definition in
intervals. cTnT is a treatment variable and
ECGfindings is theeffectoroutcome vari-
able. The effect is not dichotomous, but
polytomous as the ECG finding is not sim-
ply a positive or negative result. It is cus-Bernstein et al.: GOLDminer method fordiagnosis ofmyocardial infarction 265
Table 4. Expected odds and odds ratios from Table 3.
TnT,ECGIDx 0 1 2 3
(odds/OR)
2,4 1/1 6.26/789.22 62.29/622865 166/4.6x108
1,4 1/1 2.35/295.91 8.76/87560 8.7/2.6x107
2,3 1/1 1.93/243.18 5.91/59134 4.8/1.4x107
0,4 1/1 0.88/110.95 1.23/12309 0.5/1.4x106
1,3 1/1 0.72/91.18 0.83/8313 0.3/7.6x105
2,2 1/1 0.59/74.93 0.56/5614 0.1/4.2x105
0,3 1/1 0.27/34.18 0.12/1169 0.01/4x104
2,1 1/1 0.18/23.09 0.05/533 0/1.2x104
0,2 1/1 0.08/10.53 0.01/111 0/1169
0,1 1/1 0.03/3.25 0/10.53 0/34.2
0,0 1/1 0.01/1 0 0
Odds-Raffios Effects Plot exp(beta) =1.02 CPEKGT
3200 -
2400 - 142
1600-
800
@40
.20
.10
/
A* t ** A A A A
0 1 2 3
SDX Pardal Y
Figure 3. GOLDminerTM Y-view of the CP/ECG/cTnT coded classes versus the full
diagnoses (O[other], 1[angina], 2[non QMI], 3[QMI]). The pattern classes are formed
using typical or atypical chest pain combined with the features used in Figure 1 that
describe cTnT and ECG.
tomary to do a logistic regression for a
binary valued outcome, but the choices are
normal ECG, ST elevation, Q-wave, ST
depression/T wave inversion, and other. It
is noteasy to examine multiple alternatives
with the logistic regression model. The
square, diamond, circle, pentagon, and tri-
angle symbols in the plot are opposite the
observed odds-ratios, displayed on the
opposite Y-axis. The solid lines show the
expected odds-ratios under the model. The
cTnT values on the Y-axis are compared266 Bernstein etal.: GOLDminer method for diagnosis ofmyocardial infarction
with the ECG findings as the response
variables on the X-axis. The symbols are
aligned at the bottom showing the relative
closeness of the cTnT result to the expect-
ed ECG finding. The arrows show their
positions relative to the outcome cate-
gories. cTnT values above 0.1 ng/ml have
odds-ratios from 2 to 34 with increasing
relationship to diagnostic ECGs.
Figure 2 is a GOLDminerTm plot [19,
20] Y-view of the odds-ratios for and
against AMI using the syndromic classes
formed by the cTnT at a cutoff of > 0.1
ng/ml with diagnostic versus non-diagnos-
tic ECG findings. The chi square = 172.7
is significant at p = 1.9 x 10-39. The pat-
terns with both 0 versus both l's of cTnT
(0.1 ng/ml) and ECG positive have odds-
ratios for AMI of 0.358 and 65.941,
respectively. In the case of the cTnT(-)
and ECG(-) or "0,0" withAMI the odds is
calculated as 6/100.63 (= 0.06), for
cTnT(+) and ECG(-) or 1,0 without AMI
is calculated as 16/17.67 ( = 0.91), and for
the 0,1 without AMI is 9/6.61 ( = 1.36).
The odds-ratio for TREATMENT =
cTnT(+), ECG(+) or "1,1" and EFFECT =
"AMI" is calculated as 9.914/0.150 ( =
66.07). Likewise, the odds-ratio for
TREATMENT = cTnT(-), ECG(-) or
"0,0" and EFFECT = "AMI" is calculated
as 0.054/0.150 ( = 0.36). The odds ofhav-
ing AMI (versus no AMI) is 184 times as
high for the 1,1 than for the 0,0 combina-
tion of features.
We now introduce the multivariable
GOLDminerTh, which uses two or more
predictor variables regressed to a multival-
ued dependent variable. The full range of
values for the dependent variable, diag-
noses (0,1,2,3), and two predictors, cTnT
(0 to 2) (left) and ECG (0 to 4) (right) are
considered. The association is significant
at chi square = 246.10 (p = 3.6 x 10-54).
Table 3 is the observed (obs) and expected
(exp) frequencies for the predictor classes
vs. the diagnoses (Dx), and Table 4 is the
expected odds and odds ratios from Table
3. If we use three features cTnT, chest
pain, and ECG with the full range ofECG
findings and the cTnT intervals as defined
in Figure 1, we construct a three-letter
word using CP/ECG/cTnT with the value
of the variable in its assigned position.
Figure 3 is theGOLDminerrm plotY-view
ofodds ratios for the full regression vs the
diagnoses.
Constructing GOLDminer plots
yields a quantitative analysis of outcomes
that can aid in the diagnosis of AMI in
patients with equivocal ECG or clinical
findings. For instance, 26 patients without
a final diagnosis of AMI presented with
atypical chest pain and non-specific ECG
findings (ST segment depression or T
wave inversions) and had normal cTnT
values. The normal cTnT values allows us
to exclude the diagnosis of AMI at the
time ofpresentation and allow rapid triage
of the patient in the emergency depart-
ment. Conversely, in a group of patients
with typical chest pain with equivocal
ECG findings, an abnormal cTnT value
allows rapid triage for admission and
potential aggressive early intervention in
this high-risk subgroup.
DISCUSSION
Our study validates the diagnostic
utility of cTnT values at the time of pre-
sentation and is unique in several ways.
We studied the entire spectrum ofpatients
presenting to the emergency department
with a suspicion of AMI and not just
patients with chest discomfort. Secondly,
the cTnT results and the decision-making
process were separated. This had implica-
tions for test validation. The test cutoff
was determined by a process independent
of the clinical decisions used in patient
care. We then evaluated the role of serum
cTnT in the diagnosis ofAMI in relation-
ship to the other features in the diagnosis
of AMI. We argue that cTnT has greatBernstein et al.: GOLDminer method fordiagnosis ofmyocardial infarction 267
value for relieving uncertainty when the
clinical features are not definitive for
excluding AMI. The universal regression
model clarifies the underlying relationship
between the serum markers, clinical fea-
tures, and outcomes. This type of model-
ing allows us to form a classification with
features that can be displayed in a truth
table. Instead of the individual tests or
symptoms, the combinations of features
resolve uncertainty,just as as the pixels on
a screen give resolution in picture defini-
tion.
The GOLDminerTM method unmasks
the underlying autocorrelation between
cTnT and ECG findings in the data. We
use the GOLDminerTM to examine the
probability characteristics of the feature
combinations as more and more uncertain-
ty is relieved. This approach is consider-
ably more satisfying than other models
currently in use and may have future
implications for medical practice and deci-
sion making. This is especially important
in the case where there are equivocal clin-
ical and ECG findings. The diagnostic
efficiency of cTnT values at the time of
presentation coupled with clinical and
electrocardiographic findings allows rapid
decision making and patient triage result-
ing in potential enormous healthcare sav-
ings.
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